News

Medscape18h
EMA: Varicella Vaccines to Warn of Rare Encephalitis Risk
The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP)
Biodexa Announces Filing of CTA in Europe for Phase 3 Serenta Trial in Familial Adenomatous Polyposis (FAP) Biodexa ...
Europe lifts restriction on Valneva's chikungunya vaccine for elderly adults
The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...
Medscape19h
EU to Ease Clozapine Monitoring Frequency After First Year
Clozapine blood monitoring can now be reduced to every 12 weeks after 1 year of treatment, and annually after 2 years, in patients without neutropenia.
Novo Nordisk submits higher Wegovy dose to the European Medicines Agency for approval
Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European ...
European Medicines Agency Gave Positive Opinion on Novo Nordisk’s (NVO) Ozempic Label
Novo Nordisk A/S (NYSE:NVO) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 23, Novo Nordisk A ...
The Manila Times3d
Valneva Announces Lifting of European Medicines Agency’s Temporary Restriction on Use of Chikungunya Vaccine IXCHIQ® in Elderly
July, 11 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating ...
Pharmabiz4d
Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane
Bayer seeks European marketing authorization for investigational contrast agent, gadoquatrane: Berlin Friday, July 11, 2025, 11:00 Hrs [IST] Bayer announced the submission of a ma ...